Company Name | Exchange | Ticker | Last Price | Total Analyst Coverage |
Upgrade/ Downgrade |
Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
---|---|---|---|---|---|---|---|---|---|
Orbit Garant Drilling Inc | TSX | OGD | 1.52 | 4 | Upgrade to buy from hold | Ben Jekic | Industrial Alliance Securities | 1.75 | 15.1% |
Probe Mines Ltd | TSXV | PRB | 2.74 | 10 | Initiate with outperform | David Sadowski | Raymond James | 3.50 | 27.7% |
Eldorado Gold Corp | TSX | ELD | 7.33 | 25 | Downgrade to hold from buy | Craig Sterling | EVA Dimensions | NA | NA |
Sierra Metals Inc | TSX | SMT | 2.14 | 4 | Downgrade to market perform from buy | Cliff Hale-Sanders | Cormark Securities Inc. | 2.50 | 16.8% |
Industrial Alliance Securities upgraded Orbit Garant Drilling Inc (TSX: OGD), a mineral drilling company engaged in operating a surface and underground diamond drilling business, to buy from hold increasing its price target to C$1.75 from C$1.30, indicating an upside of 15.1% from current levels.
Raymond James initiated coverage on Probe Mines Ltd (TSXV: PRB), engaged in exploring gold resources, with an outperform rating assigning a 12-month price target of C$3.50, indicating an upside of 27.7% from current levels.
EVA Dimensions downgraded Eldorado Gold Corp (TSX: ELD), a gold exploration, development, mining and production company, to hold from buy. The rating firm did not assign any price target to the stock.
Cormark Securities Inc. downgraded Sierra Metals Inc (TSX: SMT), a precious and base metals producer, to market perform from buy lowering its price target to C$2.50 from C$2.75, indicating an upside of 16.8% from current levels.
Company Name | Exchange | Ticker | Last Price |
Total Analyst Coverage |
Upgrade/ Downgrade |
Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
---|---|---|---|---|---|---|---|---|---|
Endo Health Solutions Inc | NASDAQ | ENDP | 65.75 | 22 | Upgrade to hold from sell | Steven Silver | S&P Capital IQ | 67.00 | 1.9% |
Ariad Pharmaceuticals Inc | NASDAQ | ARIA | 8.99 | 21 | Upgrade to outperform from market perform | Jim Birchenough | BMO Capital Markets | 14.00 | 55.7% |
Fifth Street Finance Corp | NASDAQ | FSC | 9.39 | 14 | Upgrade to buy from neutral | Andrew Kerai | National Securities | 11.00 | 17.1% |
Commercial Metals Co | NYSE | CMC | 18.94 | 13 | Initiate with neutral | Nathan Littlewood | Credit Suisse | 22.00 | 16.2% |
Nabors Industries Ltd | NYSE | NBR | 17.04 | 27 | Initiate with equalweight | Matthew Marietta | Stephens Inc | 20.00 | 17.4% |
S&P Capital IQ upgraded Endo Health Solutions Inc (NASDAQ: ENDP), a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services, to hold from sell increasing its price target to $67.00 from $65.00, indicating an upside of 1.9% from current levels. Recently, ENDP reported that NuPathe Inc. (NASDAQ: PATH) has terminated its merger agreement with Endo and paid a termination fee of $5 million to ENDP.
Ariad Pharmaceuticals Inc (NASDAQ: ARIA), a global oncology company focused on the discovery, development and commercialization of medicines for cancer patients, was upgraded to outperform from market perform at BMO Capital Markets increasing its price target to $14.00 from $8.00, indicating an upside of 55.7% from current levels. Analyst Jim Birchenough foresees a significant value in the company’s assets and believes that it will attract interest from large pharmaceutical companies.
National Securities upgraded Fifth Street Finance Corp (NASDAQ: FSC), a specialty finance company that lends to and invests in small and mid-sized companies in connection with investments by private equity sponsors, to buy from neutral with a price target of $11.00, indicating an upside of 17.1% from current levels. FSC is scheduled to report its earnings for the period ended December 31, 2013 on February 6, 2014 before market opens.
Credit Suisse initiated coverage on Commercial Metals Co (NYSE: CMC), engaged in manufacturing, recycling and marketing steel and metal products, related materials and services, with a neutral rating assigning a 12-month price target of $22.00, indicating an upside potential of 16.2% from current levels.
Coverage on Nabors Industries Ltd (NYSE: NBR), a land drilling contractor and land well-servicing and work-over contractors, was initiated with equal-weight at Stephens Inc with a price target of $20.00, indicating an upside of 17.4% from current levels.